In the ongoing saga of Twitter's battle against COVID-19 "misinformation," Fox News host Laura Ingraham is the latest casualty. On March 20, 2020, Ingraham (@IngrahamAngle) tweeted: "Lenox Hill in New York among many hospitals already using Hydroxychloroquine with very promising results. One patient was described as "Lazarus" who was seriously ill from Covid-19, already released." On March 30, Twitter demanded that this tweet be removed. According to a Twitter spokesperson, this was due to a violation of its misleading information policy regarding heightened-risk health claims. In other words, Twitter consider the tweet a violation of its new policy regarding tweeting about COVID-19. 

While a Fox News story about the Ingraham segment that this tweet referred to does carry a correction that the guest does not work for Lenox Hill and that his views are his own, it is also the case that the FDA approved the treatment that Ingraham's guest was referencing on March 29, the day before Twitter demanded that the 10-day-old tweet be removed. The malaria drug that is showing promise as a treatment for the COVID-19 Coronavirus started being tested under FDA approval at hospitals in New York on March 24, for patients who were on "compassion care," or otherwise not expected to survive. 

Twitter did not address my question as to whether the FDA approval will cause them to re-evaluate their demands. As the demand to remove this tweet was made after the FDA approval was issued, it seems unlikely that the FDA approval of the treatment will have any significant impact on Twitter's crackdown in this area. There are critics who do not believe that the FDA should have issued the emergency approval for the treatment without more rigorous testing. It seems that Twitter is siding with these critics over the FDA instead of allowing for a discussion from both sides of the argument.

Previously, Twitter had also censored both Rudy Guiliani, attorney for President Donald Trump, and Turning Point USA founder Charlie Kirk for tweeting about this drug.